• Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients

  • Nov 22 2024
  • Duración: 4 m
  • Podcast

Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In patients with heart failure with preserved ejection fraction (HFpEF) and obesity, tirzepatide significantly reduced the composite risk of cardiovascular death or worsening heart failure and improved health status compared to placebo, though it was associated with higher gastrointestinal side effects.


    For summary, click here.


    Packer M, Zile MR, Kramer CM, et al. (2024). “Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.” New England Journal of Medicine. DOI: 10.1056/NEJMoa2410027


    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles